Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania maintains a much higher level of energy self-sufficiency compared to the EU average, though certain sectors show diverging trends, according to Eurostat.
The National Road Investment Company (CNIR) has submitted documentation to the National Public Procurement Agency for the tender of an Express Road connecting the A0 Bucharest North Motorway to the future Terminal 2 of Henri Coandă-Otopeni International Airport. The estimated investment value exceeds RON 400 million (€80 million).
Turkish investor Yeşilyurt Enerji has successfully secured a €20 million financing package from the Netherlands-based bank YapiKredi
Romania has reached a significant milestone in its agricultural trade strategy by securing access to the Chinese market.
Purcari Wineries has signed documentation to acquire Serve Ceptura, pending corporate and regulatory approvals including clearance from Romania's Commission for the Examination of Foreign Direct Investments.